Givaudan sales surge boosted by strong fragrance demand calming US economic slowdown fears

Swiss fragrances and flavours giant Givaudan reported 'robust' sales for the first nine months of the year, a performance that led to a rise in its share price on Tuesday and helped to alleviate market concerns regarding a potential economic slowdown in the United States, according to recent analyst commentary.

For the period spanning January through September, the Geneva-based group recorded sales of 5.7 billion Swiss francs, equivalent to 6.1 billion euros. This figure represents a significant 5.7% increase when accounting for currency fluctuations and acquisitions, and a 1.7% rise in reported Swiss-franc terms, demonstrating steady growth across its operations.

A primary driver of this impressive growth continued to be the fine fragrance segment, which saw sales surge by 18.7%. This notable expansion comes despite a particularly challenging comparison base, following several consecutive years of double-digit growth in this specific area, underscoring the enduring strength of Givaudan's luxury fragrance portfolio.

The company also confirmed its ongoing strategy to implement price increases across its product lines. This measure is designed to fully counteract the rising costs of raw materials and increased customs duties, ensuring that profitability is maintained amidst inflationary pressures in the global supply chain, as stated in its press release.

Breaking down the performance by division, the Fragrances and Beauty segment, which encompasses a broad range of products including fragrances for laundry and personal care, as well as skincare ingredients, generated sales of 2.9 billion francs. This marked an 8% increase when adjusted for currency effects and acquisitions compared to the same period in the previous year, highlighting robust demand in these consumer-focused categories.

Conversely, the flavours business, catering to the food industry, posted sales totalling 2.8 billion francs, representing a solid 3.4% increase. Notably, growth within the critical North American market for this division stood at 3.9%, indicating continued penetration and success in a key geographical region.

These financial outcomes largely align with the consensus forecasts from analysts polled by the Swiss agency AWP, who had, on average, anticipated total sales of 5.7 billion francs. Their divisional expectations were also met, with 2.9 billion francs projected for the Fragrances and Beauty division and 2.8 billion for flavours, reinforcing market confidence in Givaudan's performance.

Following an initial opening jump of over 2%, Givaudan's shares maintained an upward trajectory, trading 0.86% higher at 3,396 Swiss francs by 08:28 GMT. This positive movement contrasted with the broader trend of the SMI, the Swiss stock exchange's benchmark index, which experienced a 0.20% decline. Despite this Tuesday boost, the stock has seen a nearly 14% decrease since January, a trend that Daniel Bürki, an analyst at Zurich Cantonal Bank, attributes to a broader "general weakness in the food ingredients sector" on the stock market, influenced by prevailing concerns about consumer spending.

In a recent market note, Bürki acknowledged "a slight slowdown" in third-quarter growth for Givaudan, but noted that this was an anticipated development given the exceptionally high comparison base from previous periods. Despite this, he still characterized the nine-month sales figures as "solid," reinforcing the underlying strength of the company's financial position.

Echoing this sentiment, Arben Hasanaj, an analyst at Vontobel, also described Givaudan's sales as "robust." In his market commentary, Hasanaj suggested that these results successfully "dispel the markets' immediate fears," specifically citing concerns about "a weakening in the US" economy or a potential "decline in perfumery" demand, thereby offering reassurance to investors.

While Givaudan refrains from issuing short-term financial forecasts, it consistently outlines a comprehensive five-year strategic roadmap. For the period extending to the end of 2025, the group had originally targeted sales growth of 4% to 5%. However, with average sales growth already reaching 7.2% between 2021 and 2024, the company now believes it is "very likely to exceed the upper limit" of this initial target. Furthermore, Givaudan unveiled its ambitious objectives for 2030 at the end of August, setting a new growth target of 4% to 6% over the next five years, indicating sustained optimism for its long-term trajectory.